Skip to main content
SpringerLink
Log in

Ipilimumab/nivolumab

Colitis and diarrhoea: 11 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Yanai S, et al. Immune checkpoint inhibitor-induced diarrhea: Clinicopathological study of 11 patients. Digestive Endoscopy 32: 616-620, No. 4, May 2020. Available from: URL: http://doi.org/10.1111/den.13555

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ipilimumab/nivolumab. Reactions Weekly 1810, 120 (2020). https://doi.org/10.1007/s40278-020-80140-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-80140-2

Search

Navigation